Adenoid Hypertrophy. Hypertrophy of adenoids
Conditions
Interventions
Intervention 1: Intervention group: monteleukast tab daily 5 mg for 2 months plus nasal mometason daily. Patients are followed in clinic or on phone in two sessions.drug is produced in Abidi Pharmac
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
2 Years to 14 Years
Inclusion criteria
Inclusion criteria: hypertrophy of adenoids confirmed clinically and radiologically Current use of nasal Mometason No contraindication for corticosteroids or monteleukast No previous adenoidectomy Patients and parents consent age 2 to 14 years
Exclusion criteria
Exclusion criteria: Allergic to nasal corticosteroids or antileukotriens Craniofacial, neuromuscular disorders or syndromes Acute upper respiratory tract infection Use of corticosteroids or antibiotics within last 2 weeks drug reactions requiring medication change patients who require surgical treatment while participating patient or parent refusal
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mouth breathing. Timepoint: before intervention and 1 months after and 2 months after intervention. Method of measurement: questionnaire.;Nasal Voice. Timepoint: before intervention and 1 months after and 2 months after intervention. Method of measurement: questionnaire.;Snoring. Timepoint: before intervention and 1 months after and 2 months after intervention. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahar Pourroshani
Tehran University of Medical Sciences
Outcome results
None listed